Clinical Trial Update: Study of the Apatinib Combine With POF Versus POF in Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apatinib in combination with POF versus POF in gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Gastric Adenocarcinoma, Advanced Cancer | Phase 2 | Status: UNKNOWN